The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

Show other versions (1)

Renin-angiotensin-aldosterone system inhibitors prevent the progression of kidney disease in patients with diabetic nephropathy, and we studied how that benefit varies by the type of diabetes and baseline urinary albumin. We pooled data from 49 randomized controlled trials in a meta-analysis using t...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Taylor, K, Stevens, R, Blacklock, C, Roberts, N, Pugh, C, Farmer, A, Hirst, J
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2012

Eitemau Tebyg

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
gan: Hirst, J, et al.
Cyhoeddwyd: (2012)

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.
gan: Blacklock, C, et al.
Cyhoeddwyd: (2011)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
gan: Audrey Koitka, et al.
Cyhoeddwyd: (2008-01-01)

Renin Angiotensin Aldosterone System Gene Polymorphisms among Type 2 Diabetic Patients with Retinopathy and Nephropathy
gan: Vaishali S. Pawar, et al.
Cyhoeddwyd: (2024-12-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
gan: K. V. Skobeleva, et al.
Cyhoeddwyd: (2021-06-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
gan: Yan-Huan Feng, et al.
Cyhoeddwyd: (2016-01-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
gan: K. V. Skobeleva, et al.
Cyhoeddwyd: (2021-06-01)

Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
gan: Joshua J. Joseph, et al.
Cyhoeddwyd: (2018-09-01)

Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy
gan: Dongqi Zhou, et al.
Cyhoeddwyd: (2024-01-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
gan: Akira Nishiyama, et al.
Cyhoeddwyd: (2010-01-01)

The efficacy and safety of dual blockage of the renin-angiotensin-aldosterone system in patients with type 2 diabetes, hypertension and obesity without renal dysfunction
Cyhoeddwyd: (2012-09-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
gan: Andre Feldman, et al.
Cyhoeddwyd: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
gan: Andre Feldman, et al.
Cyhoeddwyd: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
gan: Andre Feldman, et al.
Cyhoeddwyd: (2020-11-01)

Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
gan: José Silva-Cardoso, et al.
Cyhoeddwyd: (2022-10-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
gan: D.D. Ivanov
Cyhoeddwyd: (2021-09-01)

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities
gan: C. M. Gant, et al.
Cyhoeddwyd: (2023-08-01)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects
gan: Ramachandran, Vasudevan, et al.
Cyhoeddwyd: (2009)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects
gan: Stanslas Johnson, et al.
Cyhoeddwyd: (2009-02-01)

Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus
gan: Ilić Vesna, et al.
Cyhoeddwyd: (2014-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
gan: Yuichiro Ueda, et al.
Cyhoeddwyd: (2016-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
gan: Yuichiro Ueda, et al.
Cyhoeddwyd: (2016-09-01)

Novel Class of Central Renin Angiotensin Aldosterone System Inhibitor: Firibastat
Cyhoeddwyd: (2022-05-01)

Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
gan: Filipe Ferrari, et al.
Cyhoeddwyd: (2021-04-01)

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
gan: Jordan Loader, et al.
Cyhoeddwyd: (2021-08-01)

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
gan: Marat Z. Saidov, et al.
Cyhoeddwyd: (2019-12-01)

The renin angiotensin aldosterone system and COVID-19
gan: Hadeel A. Alsufyani, et al.
Cyhoeddwyd: (2020-08-01)

Beyond the circulating renin angiotensin aldosterone system
gan: Walmor eDe Mello
Cyhoeddwyd: (2014-07-01)

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
gan: Tobias Zimmermann, et al.
Cyhoeddwyd: (2021-04-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
gan: Xinwu Huang, et al.
Cyhoeddwyd: (2017-06-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
gan: Atsuhiro Ichihara, et al.
Cyhoeddwyd: (2010-01-01)

Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions
gan: Paolo Cimaglia MD, et al.
Cyhoeddwyd: (2022-05-01)

A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
gan: Zohreh Rahimi, et al.
Cyhoeddwyd: (2014-01-01)

Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
gan: Angela Madalina Lazar
Cyhoeddwyd: (2021-07-01)

Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
gan: Juan Caro-Codón, et al.
Cyhoeddwyd: (2022-10-01)

Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.
gan: Jungchan Park, et al.
Cyhoeddwyd: (2021-01-01)

Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis
gan: Yu-qiong Lin, et al.
Cyhoeddwyd: (2024-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
gan: M. L. Maksimov, et al.
Cyhoeddwyd: (2010-04-01)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
gan: Eliecer Coto, et al.
Cyhoeddwyd: (2021-03-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
gan: Maricica Pacurari, et al.
Cyhoeddwyd: (2014-01-01)